Xtant Medical Holdings Inc當前公司基本面數據相對健康,增長潛力很大。當前估值合理,在醫療設備與耗材行業排名45/208位。機構持股佔比非常高,近一個月多位分析師給出公司評級為強力買入。最高目標價1.50。中期看,股價處於上升通道。近一個月,市場表現很強,技術面和基本面綜合得分較高,很強的走勢得到基本面和技術面的印證。目前股價在壓力位和支撐位之間,可以做區間波段操作。
Xtant Medical Holdings Inc評分
相關信息
行業排名
45 / 208
全市場排名
125 / 4582
所屬行業
醫療設備與耗材
壓力支撐
由於公司未披露,未能獲取相關數據
多維評測
本期評分
上期評分
分析師目標
基於
2
分析師
強力買入
評級
1.500
目標均價
+111.92%
漲幅空間
數據免責聲明:分析師評級與目標價由LSEG提供,僅供參考,不應當作投資建議
Xtant Medical Holdings Inc亮點
亮點風險
Xtant Medical Holdings, Inc. is a global medical technology company. The Company is focused on the design, development, and commercialization of a comprehensive portfolio of orthobiologics and spinal implant fixation systems to facilitate spinal fusion in complex spine, deformity, and degenerative procedures. Its products are used by orthopedic spine surgeons and neurosurgeons to treat a variety of spinal disorders in the cervical, thoracolumbar, and interbody spine. Its biomaterial products include OsteoSponge, OsteoSelect DBM putty, OsteoSelect Plus DBM putty, OsteoWrap, OsteoVive, OsteoFactor, line of 3Demin products, as well as other allografts. It offers a comprehensive line of products that are used to treat a variety of spinal and sacroiliac conditions, including trauma, degeneration, deformity and tumor. Its key spinal implant product lines include Cervical products, Thoracolumbar products, Sacroiliac Joint products, Interbody products and Interlaminar Stabilization products.
Xtant Medical Holdings, Inc. is a global medical technology company. The Company is focused on the design, development, and commercialization of a comprehensive portfolio of orthobiologics and spinal implant fixation systems to facilitate spinal fusion in complex spine, deformity, and degenerative procedures. Its products are used by orthopedic spine surgeons and neurosurgeons to treat a variety of spinal disorders in the cervical, thoracolumbar, and interbody spine. Its biomaterial products include OsteoSponge, OsteoSelect DBM putty, OsteoSelect Plus DBM putty, OsteoWrap, OsteoVive, OsteoFactor, line of 3Demin products, as well as other allografts. It offers a comprehensive line of products that are used to treat a variety of spinal and sacroiliac conditions, including trauma, degeneration, deformity and tumor. Its key spinal implant product lines include Cervical products, Thoracolumbar products, Sacroiliac Joint products, Interbody products and Interlaminar Stabilization products.
公司代碼XTNT
公司Xtant Medical Holdings Inc
CEOBrowne (Sean E)
網址https://xtantmedical.com/
常見問題
Xtant Medical Holdings Inc(XTNT)的當前股價是多少?
Xtant Medical Holdings Inc(XTNT)的當前股價是 0.797。
Xtant Medical Holdings Inc 的股票代碼是什麼?
Xtant Medical Holdings Inc的股票代碼是XTNT。
Xtant Medical Holdings Inc股票的52週最高點是多少?
Xtant Medical Holdings Inc股票的52週最高點是0.950。
Xtant Medical Holdings Inc股票的52週最低點是多少?
Xtant Medical Holdings Inc股票的52週最低點是0.340。
Xtant Medical Holdings Inc的市值是多少?
Xtant Medical Holdings Inc的市值是111.54M。
Xtant Medical Holdings Inc的淨利潤是多少?
Xtant Medical Holdings Inc的淨利潤為-16.45M。
現在Xtant Medical Holdings Inc(XTNT)的股票是買入、持有還是賣出?
根據分析師評級,Xtant Medical Holdings Inc(XTNT)的總體評級為--,目標價格為1.500。
Xtant Medical Holdings Inc(XTNT)股票的每股收益(EPS TTM)是多少
Xtant Medical Holdings Inc(XTNT)股票的每股收益(EPS TTM)是0.013。